TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A preliminary modeling study estimates that raising blood pressure control to levels achieved by high-performing U.S. health systems could prevent 518,476 cardiovascular deaths each year across 20 upper- and lower-middle-income countries. The figure is a modeled estimate, not a count of deaths already prevented or a forecast guaranteed by the researchers.
A preliminary modeling study presented at the American Heart Association’s Hypertension Scientific Sessions 2026 estimates that improving blood pressure control could prevent 518,476 cardiovascular deaths each year across 20 upper- and lower-middle-income countries. The estimate assumes preventive care reaches about 80% of eligible patients, a level seen in high-performing U.S. health systems; it describes potential impact, not observed deaths prevented.
Researchers analyzed existing data to estimate how many deaths could be avoided if access to several evidence-based preventive services increased from current levels to roughly 80% of eligible patients. Blood pressure control had the largest modeled effect among the services assessed, ahead of statin treatment for high cholesterol and blood sugar control for people with diabetes.
Under that scenario, the study estimated 518,476 annual cardiovascular deaths could be prevented through hypertension control, compared with 340,682 through statin treatment when indicated and 309,520 through improved glucose control. The estimates apply to the 20 countries studied and reflect the researchers’ model assumptions; they are not a tally of outcomes from a treatment program.
The analysis found that about one in five adults with hypertension in the included countries had blood pressure below 140/90 mm Hg. The researchers also reported that 16% of people with high cholesterol used statins, while 39% of people with Type 1 or Type 2 diabetes had blood sugar below the study’s optimal threshold. The report said screening uptake for the cancer tests it assessed ranged from 14% to 26%.
The Reach of Better Blood Pressure Care
The findings point to a sizeable potential benefit from improving routine prevention, particularly in countries where access to diagnosis, ongoing treatment and follow-up remains limited. The study’s estimate of more than half a million cardiovascular deaths annually is the largest modeled reduction among the preventive services compared, making hypertension control a leading opportunity within the analysis.
The report says the estimated opportunity was similar in the two income groups: 223,282 annual deaths in upper-middle-income countries and 223,655 in lower-middle-income countries. These figures represent modeled potential under the study’s target scenario, not separate observed changes. For health systems, the results suggest that expanding blood pressure care could have a broad impact alongside measures addressing cholesterol and diabetes.
High blood pressure often requires continued monitoring and management, and the study did not test a particular national program or treatment. Its relevance is in highlighting the possible scale of missed prevention across the countries studied. It does not show how quickly services could reach the modeled target or what resources would be needed to do so.
As an affiliate, we earn on qualifying purchases.
How the Study Set Its Targets
The work was presented at the American Heart Association’s Hypertension Scientific Sessions, held in Arlington, Virginia, from October 7 to 11, 2026. The meeting focuses on research into high blood pressure and its links with heart and kidney disease, stroke and other conditions.
Researchers modeled six preventive services: blood pressure control, statin treatment when indicated, glucose control for people with diabetes, and screening for colon, breast and cervical cancers. Eligibility and targets were based on major clinical guidelines. The comparison target—approximately 80% of eligible patients receiving services—was drawn from levels in high-performing U.S. health systems.
The analysis covered 20 countries with high numbers of deaths from noncommunicable diseases, divided into upper- and lower-middle-income groups using World Bank categories. No low-income countries were included, so the estimates cannot describe potential effects in those countries. In the analysis, colon cancer screening had the largest estimated effect among the cancer screening services, with 206,767 colon cancer-related deaths potentially prevented annually at the modeled target.
“Expanding treatment of high blood pressure to more people prevented the most deaths.”
— Scott Pilla, M.D., M.H.S., associate professor of medicine at Johns Hopkins University School of Medicine and a study author
As an affiliate, we earn on qualifying purchases.
Limits of the Mortality Estimates
The 518,476 figure is a model estimate based on increasing service use to a specified target. It does not establish how many deaths would actually be prevented if countries expanded treatment, nor does it identify the cost, staffing or time required to reach 80% coverage. The supplied report describes the analysis as preliminary research presented at a scientific meeting.
The study includes 20 upper- and lower-middle-income countries but no low-income countries, limiting how far its results can be generalized. The available report does not name all 20 countries or provide detailed country-by-country estimates beyond the two income-group figures. It also does not establish that every eligible person could safely or practically receive the modeled services under current health systems.
The reported hypertension-control measure uses a threshold of below 140/90 mm Hg. The American Heart Association’s 2025 adult guideline sets a treatment goal below 130/80 mm Hg. These are different thresholds, and the report does not say that the study’s one-in-five control statistic uses the guideline’s more intensive target.
home blood pressure tracking device
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
From Modeling to Wider Treatment
The next step is not a confirmed global rollout: the study estimates possible effects, while decisions on policy and implementation remain with health authorities and health systems. Further research and country-level planning would be needed to determine which barriers—such as screening access, medication supply, follow-up or affordability—most limit blood pressure control in each setting.
Clinicians and policymakers can compare local care levels with the study’s modeled target, but the estimate alone does not prescribe a single intervention. The American Heart Association’s adult guideline recommends a blood pressure treatment goal of less than 130/80 mm Hg; individual care decisions should be made with a qualified health professional. The available report does not specify a publication date for a full study paper or announce a follow-up milestone.
As an affiliate, we earn on qualifying purchases.
Key Questions
How many deaths could better blood pressure control prevent?
The study estimates that reaching its modeled blood pressure-control target could prevent 518,476 cardiovascular deaths each year across the 20 countries analyzed. This is a projection, not an observed result.
Which countries were included?
The analysis covered 20 upper- and lower-middle-income countries selected for high numbers of noncommunicable-disease deaths. The supplied report does not list every country, and it says no low-income countries were included.
How did the study define its target for preventive care?
Researchers modeled care reaching about 80% of eligible patients, matching levels reported in high-performing U.S. health systems. That target was used to estimate potential impact; it is not evidence that the same coverage has been achieved across the study countries.
Was blood pressure control more impactful than the other services studied?
Yes, in the model. Hypertension control had the largest estimated annual impact, compared with 340,682 deaths potentially prevented through indicated statin treatment and 309,520 through glucose control for people with diabetes.
Does the study prove that these deaths will be prevented?
No. The result is a preliminary model-based estimate that depends on assumptions about expanding preventive care. Actual outcomes would depend on whether countries can reach the target and sustain effective care.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
